Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
- PMID: 29540411
- PMCID: PMC5857696
- DOI: 10.1136/bmjopen-2017-019280
Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
Abstract
Introduction: There is rising awareness that we need multidisciplinary approaches integrating psychological treatments for schizophrenia, but a comprehensive evidence based on their relative efficacy is lacking. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs) to rank psychological treatments for schizophrenia according to their efficacy, acceptability and tolerability.
Methods and analysis: We will include all RCTs comparing a psychological treatment aimed at positive symptoms of schizophrenia with another psychological intervention or with a no treatment condition (waiting-list and treatment as usual). We will include studies on adult patients with schizophrenia, excluding specific subpopulations (eg, first-episode patients or patients with psychiatric comorbidities). Primary outcome will be the change in positive symptoms on a published rating scale. Secondary outcomes will be acceptability (dropout), change in overall and negative symptoms of schizophrenia, response, relapse, adherence, depression, quality of life, functioning and adverse events. Published and unpublished studies will be sought through database searches, trial registries and websites. Study selection and data extraction will be conducted by at least two independent reviewers. We will conduct random-effects NMA to synthesise all evidences for each outcome and obtain a comprehensive ranking of all treatments. NMA will be conducted in Stata and R within a frequentist framework. The risk of bias in studies will be evaluated using the Cochrane Risk of Bias tool and the credibility of the evidence will be evaluated using an adaptation of the Grading of Recommendations Assessment, Development and Evaluation framework to NMA, recommended by the Cochrane guidance. Subgroup and sensitivity analyses will be conducted to assess the robustness of the findings.
Ethics and dissemination: No ethical issues are foreseen. Results from this study will be published in peer-reviewed journals and presented at relevant conferences.
Prospero registration number: CRD42017067795.
Keywords: adult psychiatry; network meta-analysis; psychological interventions; psychotherapy.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: SL in the past 3 years has received honoraria for consulting from Roche, TEVA, Otsuka, Lundbeck and LB Pharma; for lectures from Otsuka, Lundbeck, Janssen, ICON, Lilly, Sanofi Aventis, AOP Orphan, Roche and Servier; and for a publication from Roche. TAF has received lecture fees from Eli Lilly, Janssen, Meiji, Mitsubishi-Tanabe, MSD and Pfizer and consultancy fees from Takeda Science Foundation. He has received royalties from Igaku-Shoin and Nihon Bunka Kagaku-sha publishers. He has received research support from Mochida and Mitsubishi-Tanabe.
Similar articles
-
Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence.BMJ Open. 2020 Jan 19;10(1):e035073. doi: 10.1136/bmjopen-2019-035073. BMJ Open. 2020. PMID: 31959613 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.Cochrane Database Syst Rev. 2014 Nov 1;2014(11):CD011142. doi: 10.1002/14651858.CD011142.pub2. Cochrane Database Syst Rev. 2014. PMID: 25362239 Free PMC article.
Cited by
-
Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials.Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):779-810. doi: 10.1007/s00406-022-01526-1. Epub 2022 Dec 8. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36477405 Free PMC article.
-
The controversy about cognitive behavioural therapy for schizophrenia.World Psychiatry. 2019 Jun;18(2):235-236. doi: 10.1002/wps.20636. World Psychiatry. 2019. PMID: 31059624 Free PMC article. No abstract available.
-
Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis.Neuroimage Clin. 2018;20:1053-1061. doi: 10.1016/j.nicl.2018.10.011. Epub 2018 Oct 10. Neuroimage Clin. 2018. PMID: 30343250 Free PMC article.
-
Cognitive-behavioral therapy for the improvement of negative symptoms and functioning in schizophrenia: A systematic review and meta-analysis of randomized controlled trials.PLoS One. 2025 May 20;20(5):e0324685. doi: 10.1371/journal.pone.0324685. eCollection 2025. PLoS One. 2025. PMID: 40392926 Free PMC article.
-
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis.BMC Psychiatry. 2018 Dec 4;18(1):380. doi: 10.1186/s12888-018-1964-8. BMC Psychiatry. 2018. PMID: 30514268 Free PMC article.
References
-
- National Collaborating Centre for Mental Health. Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (Clinical Guideline CG82). London 2009.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical